Archives
|
|
Current Press Releases
aTyr Pharma to Present Data for Inflammatory Myopathy and Interstitial Lung Disease at the 2012 American College of Rheumatology Annual Meeting
Detailed Characterization of Orphan Autoimmune Disease Provides Insight into Jo-1 Antibody Response
|
|
Read more...
|
|
Current Press Releases
Fruitfly Model of a Neuropathic Disease Demonstrates
Novel Role for Proteins in the Family of aTyr Pharma's Product Class
aTyr Pharma’s Naturally Occurring Physiocrines are Novel Biotherapeutics
|
|
Read more...
|
|
Current Press Releases
aTyr Pharma Receives Industry Innovation Awards from TiE and San Diego Venture Group
Dr. John Mendlein to Speak at Upcoming BIO International Convention
|
|
Read more...
|
|
Current Press Releases
Pangu Biopharma, aTyr Pharma's Subsidiary in Hong Kong, Files Three Patent Applications
aTyr Pharma Targets for Novel Biotherapeutics Based On Physiocrines, Naturally Resected tRNA Synthetases
|
|
Read more...
|
|
Current Press Releases
aTyr Pharma Appoints Dr. Alan Ezekowitz to Therapeutic Advisory Board
Pioneer in Innate Immunity and Industry Expert to Help Guide the Discovery and Development of Physiocrine-based Medicines
|
|
Read more...
|
|
Current Press Releases
Scripps Research Institute Highlights Groundbreaking Work of aTyr Pharma Scientific Co-Founder
Research Published by Scripps Associate Professor Xiang-Lei Yang Further Validates aTyr Pharma’s Discovery Engine for Proprietary Drugs
|
|
Read more...
|
|
Current Press Releases
aTyr Pharma Expands Leadership Team to Advance New Breakthrough Medicines Based on Physiocrine Biology
Dr. Jeffrey Greve Named Vice President, Research; Dr. Andrew Cubitt Named Vice President, Intellectual Property
|
|
Read more...
|
|
Current Press Releases
Professor Wing Wong Elected to the National Academy of Sciences
aTyr Pharma Scientific Advisory Board Member Recognized for Development of Statistical Methods and Software
|
|
Read more...
|
|
Current Press Releases
aTyr Pharma Honored with Red Herring 100 North America Award for Discovering and Developing Innovative Medicines Based on Physiocrine Biology
|
|
Read more...
|
|
Current Press Releases
aTyr Pharma to Present at ChinaBio® Investor Forum in Hong Kong
Dr. James Cai, President of Hong Kong-based subsidiary
Pangu BioPharma to Speak
|
|
Read more...
|
|
|
Current Press Releases
Translational Science Expert, Dr. Melissa Ashlock, Joins aTyr Pharma to Advance Physiocrine-based Therapeutics
Dr. Ashlock Named as Vice President, External Scientific Alliances and Human Genetics
|
|
Read more...
|
Dr. James Cai Joins aTyr Pharma to Drive Clinical Development in Asia
Former AstraZeneca Exec to Lead Hong Kong-based subsidiary Pangu BioPharma
|
|
Read more...
|
|
Current Press Releases
aTyr Pharma Announces Formation of Therapeutic Advisory Board
Renowned Drug Hunters Assembled to Guide the Discovery of Innovative Protein Therapeutics Based on Physiocrine Pathways
|
|
Read more...
|
|
Archives
aTyr Pharma Completes $10.5M Series B Round
Proven Team Developing Naturally Occurring Protein Biologics for Human Therapeutics
|
|
Read more...
|
|
Current Press Releases
aTyr Pharma Secures $23M Financing From Top Tier Venture Investor
Funding to Advance Highly Innovative Drugs Based on Recently Discovered Physiocrine Biology.
|
|
Read more...
|
|
|
Current Press Releases
Dr. John Mendlein Joins aTyr Pharma as Executive Chairman
Serial Entrepreneur to Drive aTyr’s Pipeline of High Impact Medicines from a New Class of Naturally Occurring Human Proteins (Physiocrines)
aTyr announced today that John Mendlein, Ph. D., has joined their Board of Directors as Executive Chairman.
|
|
Read more...
|
|
Current Press Releases
Pangu BioPharma, aTyr Pharma’s Subsidiary in Hong Kong, Receives New Research Grant From Hong Kong Innovation and Technology Commission
The Innovation and Technology Commission of the Hong Kong government has awarded Pangu BioPharma, the Hong Kong subsidiary of aTyr Pharma, a second grant to fund research it is performing in collaboration with the Hong Kong University of Science and Technology (HKUST).
|
|
Read more...
|
|
Current Press Releases
Research Led by Co-founders of aTyr Pharma Illustrates Mechanism for Multifunctionality of a Single Protein
Publication in Nature Structural Biology Highlights Structural Basis for New Biological Activities with Therapeutic Potential
|
|
Read more...
|
|
Current Press Releases
Dr. Floyd Bloom Joins aTyr Pharma's Scientific Advisory Board
World Renown Neuroscientist Adds Pharmacology Insight on aTyr Pharma's Proprietary Protein Drug Candidates
|
|
Read more...
|
|
Current Press Releases
aTyr Pharma to Present at Biopartnering Europe Conference
Jeff Watkins, CEO, Scheduled for Podium Presentation on Monday 12 October 2009
|
|
Read more...
|
|
|
|
|
|
<< Start < Prev 1 2 Next > End >>
|
|
Page 1 of 2 |
